High-resolution genome-wide array-based comparative genome hybridization reveals cryptic chromosome changes in AML and MDS cases with trisomy 8 as the sole cytogenetic aberration

Leukemia

Volumn 20, Issue 5, 2006, Pages 840-846

  Paulsson, Kajsa ^a   Heidenblad, M ^a   Strombeck B ^a   Staaf, J ^a   Jonsson G ^a   Borg, A ^a,b   Fioretos, T ^a   Johansson, B ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Acute myeloid leukemia; Array CGH; Chromosome aberration; Myelodysplastic syndromes; Trisomy 8

Indexed keywords

ANTINEOPLASTIC AGENT; TRANSCRIPTION FACTOR RUNX1;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CHROMOSOME ANALYSIS; CHROMOSOME ISOLATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE DUPLICATION; GENE FREQUENCY; GENE NUMBER; GENETIC IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC TRANSFORMATION; HEMIZYGOSITY; HUMAN; MALE; MYELODYSPLASTIC SYNDROME; NUMERICAL CHROMOSOME ABERRATION; PRIORITY JOURNAL; TRISOMY 8;

EID: 33646143341     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404145     Document Type: Article

References (33)

1. Mitelman F, Johansson B, Mertens F. Mitelman database of chromosome aberrations in cancer. 2005. http://cgap.nci.nih.gov/Chromosomes/ Mitelman.
2. Paulsson K, Säll T, Fioretos T, Mitelman F, Johansson B. The incidence of trisomy 8 as a sole chromosomal aberration in myeloid malignancies varies in relation to gender, age, prior iatrogenic genotoxic exposure, and morphology. Cancer Genet Cytogenet 2001; 130: 160-165.
3. Albin M, Björk J, Welinder H, Tinnerberg H, Mauritzson N, Johansson B et al. Acute myeloid leukemia and clonal chromosome aberrations in relation to past exposure to organic solvents. Scand J Work Environ Health 2000; 26: 482-491.
4. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood 1998; 92: 2322-2333.
5. Wolman SR, Gundacker H, Appelbaum FR, Slovak ML. Impact of trisomy 8 (+8) on clinical presentation, treatment response, and survival in acute myeloid leukemia: A southwest oncology group study. Blood 2002; 100: 29-35.
6. Solé F, Espinet B, Sanz GF, Cervera J, Calasanz MJ, Luño E et al. Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Br J Haematol 2000; 108: 346-356.
7. Maserati E, Aprili F, Vinante F, Locatelli F, Amendola G, Zatterale A et al. Trisomy 8 in myelodysplasia and acute leukemia is constitutional in 15-20% of cases. Genes Chromosomes Cancer 2002; 33: 93-97.
8. + hematopoietic stem cell pool in myelodysplatic syndromes with trisomy 8. Blood 2002; 100: 259-267.
9. Schoch C, Kohlmann A, Dugas M, Kern W, Hiddemann W, Schnittger S et al. Genomic gains and losses influence expression levels of genes located within the affected regions: A study on acute myeloid leukemias with trisomy 8, 11, or 13, monosomy 7, or deletion 5q. Leukemia 2005; 19: 1224-1228.
10. Paulsson K, Fioretos T, Strömbeck B, Mauritzson N, Tanke HJ, Johansson B. Trisomy 8 as the sole chromosomal aberration in myelocytic malignancies: A multicolor and locus-specific fluorescence in situ hybridization study. Cancer Genet Cytogenet 2003; 140: 66-69.
11. Leroy H, Roumier C, Huyghe P, Biggio V, Fenaux P, Preudhomme C. CEBPA point mutations in hematological malignancies. Leukemia 2005; 19: 329-334.
12. Harada H, Harada Y, Niimi H, Kyo T, Kimura A, Inaba T. High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia. Blood 2004; 103: 2316-2324.
13. Heller A, Brecevic L, Glaser M, Loncarevic IF, Gebhart E, Claussen U et al. Trisomy 8 as the sole chromosomal aberration in myelocytic malignancies: A comprehensive molecular cytogenetic analysis reveals no cryptic aberrations. Cancer Genet Cytogenet 2003; 146: 81-83.
14. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998; 20: 207-211.
15. Drazinic CM, Ercan-Sencicek AG, Gault LM, Hisama FM, Qumsiyeh MB, Nowak NJ et al. Rapid array-based genomic characterization of a subtle structural abnormality: A patient with psychosis and der(18)t(5;18)(p14.1;p11.23). Am J Med Genet 2005; 134A: 282-289.
16. Heidenblad M, Schoenmakers EFPM, Jonson T, Gorunova L, Veltman JA, van Kessel AG et al. Genome-wide array-based comparative genomic hybridization reveals multiple amplification targets and novel homozygous deletions in pancreatic carcinoma cell lines. Cancer Res 2004; 64: 3052-3059.
17. Cowell JK, Matsui S-I, Wang YD, LaDuca J, Conroy J, McQuaid D et al. Application of bacterial artificial chromosome array-based comparative genomic hybridization and spectral karyotyping to the analysis of glioblastoma multiforme. Cancer Genet Cytogenet 2004; 151: 36-51.
18. Rubio-Moscardo F, Climent J, Siebert R, Piris MA, Martín-Subero JI, Nieländer I et al. Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome. Blood 2005; 105: 4445-4454.
19. Krzywinski M, Bosdet I, Smailus D, Chiu R, Mathewson C, Wye N et al. A set of BAC clones spanning the human genome. Nucl Acids Res 2004; 32: 3651-3660.
20. Ishkanian AS, Malloff CA, Watson SK, deLeeuw RJ, Chi B, Coe BP et al. A tiling resolution DNA microarray with complete coverage of the human genome. Nat Genet 2004; 36: 299-303.
21. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J et al. Normalization for cDNA microarray data: A robust composite method addressing single and multiple slide systematic variation. Nucl Acids Res 2002; 30: E15.
22. Autio R, Hautaniemi S, Kauraniemi P, Yli-Harja O, Astola J, Wolf M et al. CGH-Plotter: MATLAB toolbox for CGH-data analysis. Bioinformatics 2003; 19: 1714-1715.
23. Saal LH, Troein C, Vallon-Christersson J, Gruvberger S, Borg Å, Peterson C. BioArray Software Environment (BASE): A platform for comprehensive management and analysis of microarray data. Genome Biol 2002; 3: Software0003.
24. The Database of Genomic Variants 2005. http://projects.tcag.ca/ variation/.
25. Kallioniemi O-P, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 1994; 10: 231-243.
26. Sebat J, Lakshmi B, Troge J, Alexander J, Young J, Lundin P et al. Large-scale copy number polymorphism in the human genome. Science 2004; 305: 525-528.
27. Andreasson P, Johansson B, Arheden K, Billström R, Mitelman F, Höglund M. Deletions of CDKN1B and ETV6 in acute myeloid leukemia and myelodysplastic syndromes without cytogenetic evidence of 12p abnormalities. Genes Chromosomes Cancer 1997; 19: 77-83.
28. Cox MC, Panetta P, Venditti A, Del Poeta G, Franchi A, Buccisano F et al. Comparison between conventional banding analysis and FISH screening with an AML-specific set of probes in 260 patients. Hematol J 2003; 4: 263-270.
29. Gotlib J, Cools J, Malone III JM, Schrier SL, Gilliland DG, Coutré SE. The FIP1L1-PDGFRα fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: Implications for diagnosis, classification, and management. Blood 2004; 103: 2879-2891.
30. Marqués F, Moreau J-L, Peaucellier G, Lozano J-C, Schatt P, Picard A et al. A new subfamily of high molecular mass CDC2-related kinases with PITAI/VRE motifs. Biochem Biophys Res Commun 2000; 279: 832-837.
31. Lim K-H, Baines AT, Fiordalisi JJ, Shipitsin M, Feig LA, Cox AD et al. Activation of RalA is critical for Ras-induced tumorigenesis of human cells. Cancer Cell 2005; 7: 533-545.
32. Shapiro MJ, Powell P, Ndubuizu A, Nzerem C, Shapiro VS. The ALX Src homology 2 domain is both necessary and sufficient to inhibit T cell receptor/CD28-mediated up-regulation of RE/AP. J Biol Chem 2004; 279: 40647-40652.
33. Hayami Y, Iida S, Nakazawa N, Hanamura I, Kato M, Komatsu H et al. Inactivation of the E3/LAPTm5 gene by chromosomal rearrangement and DNA methylation in human multiple myeloma. Leukemia 2003; 17: 1650-1657.